193 related articles for article (PubMed ID: 32754639)
1. Epigenetic transcriptional reprogramming by WT1 mediates a repair response during podocyte injury.
Ettou S; Jung YL; Miyoshi T; Jain D; Hiratsuka K; Schumacher V; Taglienti ME; Morizane R; Park PJ; Kreidberg JA
Sci Adv; 2020 Jul; 6(30):eabb5460. PubMed ID: 32754639
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-466o-3p mediates β-catenin-induced podocyte injury by targeting Wilms tumor 1.
Chen Q; Chen J; Wang C; Chen X; Liu J; Zhou L; Liu Y
FASEB J; 2020 Nov; 34(11):14424-14439. PubMed ID: 32888352
[TBL] [Abstract][Full Text] [Related]
3. A murine model of Denys-Drash syndrome reveals novel transcriptional targets of WT1 in podocytes.
Ratelade J; Arrondel C; Hamard G; Garbay S; Harvey S; Biebuyck N; Schulz H; Hastie N; Pontoglio M; Gubler MC; Antignac C; Heidet L
Hum Mol Genet; 2010 Jan; 19(1):1-15. PubMed ID: 19797313
[TBL] [Abstract][Full Text] [Related]
4. Genome-Wide Analysis of Wilms' Tumor 1-Controlled Gene Expression in Podocytes Reveals Key Regulatory Mechanisms.
Kann M; Ettou S; Jung YL; Lenz MO; Taglienti ME; Park PJ; Schermer B; Benzing T; Kreidberg JA
J Am Soc Nephrol; 2015 Sep; 26(9):2097-104. PubMed ID: 25636411
[TBL] [Abstract][Full Text] [Related]
5. Integration of Cistromic and Transcriptomic Analyses Identifies Nphs2, Mafb, and Magi2 as Wilms' Tumor 1 Target Genes in Podocyte Differentiation and Maintenance.
Dong L; Pietsch S; Tan Z; Perner B; Sierig R; Kruspe D; Groth M; Witzgall R; Gröne HJ; Platzer M; Englert C
J Am Soc Nephrol; 2015 Sep; 26(9):2118-28. PubMed ID: 25556170
[TBL] [Abstract][Full Text] [Related]
6. Hsf-1 affects podocyte markers NPHS1, NPHS2 and WT1 in a transgenic mouse model of TTRVal30Met-related amyloidosis.
Petrakis I; Mavroeidi V; Stylianou K; Andronikidi E; Lioudaki E; Perakis K; Stratigis S; Vardaki E; Zafeiri M; Giannakakis K; Plaitakis A; Amoiridis G; Saraiva MJ; Daphnis E
Amyloid; 2013 Sep; 20(3):164-72. PubMed ID: 23829269
[TBL] [Abstract][Full Text] [Related]
7. Super-Enhancer-Associated Transcription Factors Maintain Transcriptional Regulation in Mature Podocytes.
Yang J; Zhang D; Motojima M; Kume T; Hou Q; Pan Y; Duan A; Zhang M; Jiang S; Hou J; Shi J; Qin Z; Liu Z
J Am Soc Nephrol; 2021 Jun; 32(6):1323-1337. PubMed ID: 33771836
[TBL] [Abstract][Full Text] [Related]
8. Activation of podocyte Notch mediates early Wt1 glomerulopathy.
Asfahani RI; Tahoun MM; Miller-Hodges EV; Bellerby J; Virasami AK; Sampson RD; Moulding D; Sebire NJ; Hohenstein P; Scambler PJ; Waters AM
Kidney Int; 2018 Apr; 93(4):903-920. PubMed ID: 29398135
[TBL] [Abstract][Full Text] [Related]
9. Wt1a, Foxc1a, and the Notch mediator Rbpj physically interact and regulate the formation of podocytes in zebrafish.
O'Brien LL; Grimaldi M; Kostun Z; Wingert RA; Selleck R; Davidson AJ
Dev Biol; 2011 Oct; 358(2):318-30. PubMed ID: 21871448
[TBL] [Abstract][Full Text] [Related]
10. WT1 regulates the expression of the major glomerular podocyte membrane protein Podocalyxin.
Palmer RE; Kotsianti A; Cadman B; Boyd T; Gerald W; Haber DA
Curr Biol; 2001 Nov; 11(22):1805-9. PubMed ID: 11719225
[TBL] [Abstract][Full Text] [Related]
11. TGF-β1 alters DNA methylation levels in promoter and enhancer regions of the WT1 gene in human podocytes.
Hamatani H; Sakairi T; Ikeuchi H; Kaneko Y; Maeshima A; Nojima Y; Hiromura K
Nephrology (Carlton); 2019 May; 24(5):575-584. PubMed ID: 29851165
[TBL] [Abstract][Full Text] [Related]
12. Notch signaling, wt1 and foxc2 are key regulators of the podocyte gene regulatory network in Xenopus.
White JT; Zhang B; Cerqueira DM; Tran U; Wessely O
Development; 2010 Jun; 137(11):1863-73. PubMed ID: 20431116
[TBL] [Abstract][Full Text] [Related]
13. TGF-beta1 reduces Wilms' tumor suppressor gene expression in podocytes.
Sakairi T; Abe Y; Kopp JB
Nephrol Dial Transplant; 2011 Sep; 26(9):2746-52. PubMed ID: 21378152
[TBL] [Abstract][Full Text] [Related]
14. CMIP interacts with WT1 and targets it on the proteasome degradation pathway.
Zhang SY; Fan Q; Moktefi A; Ory V; Audard V; Pawlak A; Ollero M; Sahali D; Henique C
Clin Transl Med; 2021 Jul; 11(7):e460. PubMed ID: 34323419
[TBL] [Abstract][Full Text] [Related]
15. Murine Denys-Drash syndrome: evidence of podocyte de-differentiation and systemic mediation of glomerulosclerosis.
Patek CE; Fleming S; Miles CG; Bellamy CO; Ladomery M; Spraggon L; Mullins J; Hastie ND; Hooper ML
Hum Mol Genet; 2003 Sep; 12(18):2379-94. PubMed ID: 12915483
[TBL] [Abstract][Full Text] [Related]
16. PINCH1 is transcriptional regulator in podocytes that interacts with WT1 and represses podocalyxin expression.
Wang D; Li Y; Wu C; Liu Y
PLoS One; 2011 Feb; 6(2):e17048. PubMed ID: 21390327
[TBL] [Abstract][Full Text] [Related]
17. Repression of CMIP transcription by WT1 is relevant to podocyte health.
Moktefi A; Zhang SY; Vachin P; Ory V; Henique C; Audard V; Rucker-Martin C; Gouadon E; Eccles M; Schedl A; Heidet L; Ollero M; Sahali D; Pawlak A
Kidney Int; 2016 Dec; 90(6):1298-1311. PubMed ID: 27650733
[TBL] [Abstract][Full Text] [Related]
18. Mutual antagonism of Wilms' tumor 1 and β-catenin dictates podocyte health and disease.
Zhou L; Li Y; He W; Zhou D; Tan RJ; Nie J; Hou FF; Liu Y
J Am Soc Nephrol; 2015 Mar; 26(3):677-91. PubMed ID: 25071087
[TBL] [Abstract][Full Text] [Related]
19. Magnesium isoglycyrrhizinate ameliorates fructose-induced podocyte apoptosis through downregulation of miR-193a to increase WT1.
Li TS; Chen L; Wang SC; Yang YZ; Xu HJ; Gu HM; Zhao XJ; Dong P; Pan Y; Shang ZQ; Zhang XQ; Kong LD
Biochem Pharmacol; 2019 Aug; 166():139-152. PubMed ID: 31085161
[TBL] [Abstract][Full Text] [Related]
20. Not too much, not too little-just the right amount: the story of YAP in the podocyte.
McEvoy CM; Yuen DA
Kidney Int; 2024 Jun; 105(6):1157-1159. PubMed ID: 38777398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
